Pfizer shares experienced a healthy 7.71% gain today as the company announced a patent victory on its biggest selling drug. This stock is technically interesting because it gapped up toward the combined resistance of the October highs and the 200 DMA. These levels have prevented the bulls from pushing the price higher on several previous occasions, and we believe that this may be the case again.



PFE_121905.jpg

You May Also Like

Related Analysis
  1. Stock Analysis

    Energy Transfer Could Learn From Williams Cos.

  2. Stock Analysis

    Is Enterprise Product's Stock a Buy Today?

  3. Stock Analysis

    Can AMD Regain GPU Market Share From NVIDIA?

  4. Stock Analysis

    Whole Foods Isn't Afraid to Leap in New Direction

  5. Stock Analysis

    Eagle Rock Soars on Vanguard Deal

Trading Center